bioleaper
Firmenname:
bioleaper
Telefon:
-
E-Mail:
guojing@bioleaper.com
Nationalität:
China
URL:
www.bioleaper.com/
Produkte insgesamt:
5615
49
50
51
52
53
54
55
56
57
Produktkatalog
Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (cudarolimab)
Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (ivuxolimab)
Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (revdofilimab)
Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (tavolixizumab)
Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (telazorlimab)
Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (vonlerizumab)
Anti-TNFRSF5 / CD40 Reference Antibody (bleselumab)
Anti-TNFRSF5 / CD40 Reference Antibody (dacetuzumab)
Anti-TNFRSF5 / CD40 Reference Antibody (Emory U. anti-CD40)
Anti-TNFRSF5 / CD40 Reference Antibody (giloralimab)
Anti-TNFRSF5 / CD40 Reference Antibody (iscalimab)
Anti-TNFRSF5 / CD40 Reference Antibody (lucatumumab)
Anti-TNFRSF5 / CD40 Reference Antibody (mitazalimab)
Anti-TNFRSF5 / CD40 Reference Antibody (ravagalimab)
Anti-TNFRSF5 / CD40 Reference Antibody (selicrelumab)
Anti-TNFRSF5 / CD40 Reference Antibody (sotigalimab)
Anti-SLC2A8 Reference Antibody (VB1-050)
Anti-SLC34A2 Reference Antibody (lifastuzumAb)
Anti-SLC34A2 Reference Antibody (upifitamab)
Anti-SLC40A1 Reference Antibody (Amgen patent anti-Ferroportin)
Anti-SLC40A1 Reference Antibody (LY2928057)
Anti-SLC44A4 Reference Antibody (ASG-5ME)
Anti-SLITRK6 Reference Antibody (sirtratumab)
Anti-Sortilin / SORT1 Reference Antibody (latozinemab)
Anti-SOST / Sclerostin Reference Antibody (blosozumab)
Anti-SOST / Sclerostin Reference Antibody (romosozumab)
Anti-SOST / Sclerostin Reference Antibody (setrusumab)
Anti-Sphingosine-1-phosphate Reference Antibody (Expression DD patent anti-SIP)
Anti-Sphingosine-1-phosphate Reference Antibody (sonepcizumab)
Anti-Spike RBD (Omicron / B.1.1.529) Antibody (P26130)
Anti-Spike RBD (Omicron BA.2 / BA.2.75) Antibody (dAb-708)
Anti-Spike RBD Antibody (P16-A3)
Anti-Spike RBD Antibody (P17-A11)
Anti-Spike RBD Antibody (P20-B4)
Anti-Spike RBD Antibody (R14-F8)
Anti-Spike RBD Antibody (R15-F7)
Anti-Spike RBD Antibody (R16-F10)
Anti-Spike RBD Antibody (RP1-E4)
Anti-Spike RBD Antibody (RP1-H5)
Anti-Spike RBD Antibody (RP6-E2)
Anti-Spike RBD Antibody (RP6-E3)
Anti-Spike S1 (Omicron BA.2 / BA.2.75 / BA.4 / BA.5) Antibody (THS-699)
Anti-Spike S1 Antibody (NCOV-S1P14-Fc)
Anti-Spike S1 Reference Antibody (CR3022)
Anti-STAB1 Reference Antibody (bexmarilimab)
Anti-STEAP1 Reference Antibody (vandortuzumAb)
Anti-STOP1 Reference Antibody (Genentech patent anti-STOP-1)
Anti-Syndecan-1 / CD138 Reference Antibody (indatuximab)
Anti-TAT226 Reference Antibody (Genentech patent anti-TAT226)
Anti-Tau Reference Antibody (bepranemab)
Anti-Tau Reference Antibody (gosuranemab)
Anti-Tau Reference Antibody (semorinemab)
Anti-Tau Reference Antibody (tilavonemab)
Anti-Tau Reference Antibody (zagotenemab)
Anti-TBFbR2 Reference Antibody (LY3022859)
Anti-TCR Reference Antibody (NKTT320)
Anti-TCR Reference Antibody (TOL101)
Anti-TEM1 / Endosialin / CD248 Reference Antibody (ontuxizumab)
Anti-TEM7R / PLXDC2 Reference Antibody (Fox Chase patent anti-TEM7R)
Anti-Tenascin C Reference Antibody (tenatumomab)
Anti-TFPI Reference Antibody (befovacimab)
Anti-TFPI Reference Antibody (concizumab)
Anti-TFPI Reference Antibody (marstacimab)
Anti-TGFb1 Reference Antibody (fresolimumab)
Anti-TGFb1 Reference Antibody (Genzyme patent anti-TGF-β)
Anti-TGFb1 Reference Antibody (M7824)
Anti-TGFb1 Reference Antibody (NIS793)
Anti-TGFb1 Reference Antibody (SRK181)
Anti-TGM2 / Transglutaminase 2 Reference Antibody (zampilimab)
Anti-TIE2 / CD202b Reference Antibody (Regeneron patent anti-TIE-2)
Anti-TIGIT Reference Antibody (domvanalimab)
Anti-TIGIT Reference Antibody (etigilimab)
Anti-TIGIT Reference Antibody (ociperlimab)
Anti-TIGIT Reference Antibody (tiragolumab)
Anti-TIGIT Reference Antibody (vibostolimab)
Anti-TIM-3 / HAVCR2 / CD366 Reference Antibody (cobolimab)
Anti-TIM-3 / HAVCR2 / CD366 Reference Antibody (sabatolimab)
Anti-Tissue factor / CD142 Reference Antibody (Chugai patent anti-TF)
Anti-Tissue factor / CD142 Reference Antibody (tisotumab)
Anti-Tissue factor / CD142 Reference Antibody (TNX-832)
Anti-TLR2 / CD282 Reference Antibody (tomaralimab)
Anti-TLR3 / CD283 Reference Antibody (CNTO5429)
Anti-TLR7 Reference Antibody (U.Tokyo patent anti-TLR7)
Anti-TMEFF1 / Tomoregulin-1 Reference Antibody (Bluefin patent anti-TMEFF1)
Anti-TMEFF2 Reference Antibody (Janssen patent anti-TMEFF2)
Anti-TMPRSS2 Reference Antibody (Regeneron patent anti-TMPRSS2 )
Anti-TNFRSF10A / TRAILR1 / CD261 Reference Antibody (mapatumumab)
Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (benufutamab)
Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (conatumumab)
Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (drozitumab)
Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (lexatumumab)
Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (tigatuzumab)
Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (tilogotamab)
Anti-TNFRSF12A / TWEAKR / CD266 Reference Antibody (enavatuzumab)
Anti-TNFRSF13C / BAFFR / CD268 Reference Antibody (ianalumab)
Anti-TNFRSF17 / BCMA / CD269 Reference Antibody (belantamab)
Anti-TNFRSF18 / GITR / CD357 Reference Antibody (Korea Natl.Cancer Ctr. patent anti-GITR)
Anti-TNFRSF18 / GITR / CD357 Reference Antibody (ragifilimab)
Anti-TNFRSF21 / DR6 / CD358 Reference Antibody (Abbvie patent anti-TNFRSF21)
Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (BMS-986178)
49
50
51
52
53
54
55
56
57
Copyright 2019 © ChemicalBook. All rights reserved